FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma - 102017

Spotlight
Video

FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma

VJOncology has 824 videos Subscribe Here

Loading........
Description: Press brief by Salah-Eddin Al-Batran, MD of the Krankenhaus Nordwest-University Cancer Center, Frankfurt, Germany, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Shared By : VJOncology
Posted on : 06/29/16
Added : 3 years ago